Ruby Gupta

948 total citations
35 papers, 719 citations indexed

About

Ruby Gupta is a scholar working on Biomaterials, Biomedical Engineering and Molecular Biology. According to data from OpenAlex, Ruby Gupta has authored 35 papers receiving a total of 719 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Biomaterials, 11 papers in Biomedical Engineering and 7 papers in Molecular Biology. Recurrent topics in Ruby Gupta's work include Nanoparticle-Based Drug Delivery (9 papers), Characterization and Applications of Magnetic Nanoparticles (6 papers) and Polyoxometalates: Synthesis and Applications (3 papers). Ruby Gupta is often cited by papers focused on Nanoparticle-Based Drug Delivery (9 papers), Characterization and Applications of Magnetic Nanoparticles (6 papers) and Polyoxometalates: Synthesis and Applications (3 papers). Ruby Gupta collaborates with scholars based in India, United States and Italy. Ruby Gupta's co-authors include Deepika Sharma, Surajit Sinha, Priyanka Kumari, Abha Meena, Bijoy K. Kuanr, V.P. Kamboj, Suchitra Banerjee, Sailendra Singh, Atul Agarwal and P. K. Nigam and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and ACS Nano.

In The Last Decade

Ruby Gupta

35 papers receiving 704 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ruby Gupta India 16 268 251 170 123 107 35 719
Chunhong Li China 15 157 0.6× 165 0.7× 311 1.8× 103 0.8× 69 0.6× 32 952
Jilai Tian China 16 201 0.8× 155 0.6× 245 1.4× 78 0.6× 102 1.0× 32 720
Marcela Tavares Luiz Brazil 18 359 1.3× 434 1.7× 364 2.1× 110 0.9× 92 0.9× 44 1.0k
Jingga Morry United States 10 164 0.6× 157 0.6× 329 1.9× 113 0.9× 69 0.6× 13 779
Mohsen Alipour Iran 16 151 0.6× 183 0.7× 392 2.3× 115 0.9× 77 0.7× 30 759
Shaymaa Mousa United States 11 137 0.5× 145 0.6× 237 1.4× 176 1.4× 58 0.5× 18 778
Chieh‐Ti Kuo United States 10 252 0.9× 264 1.1× 405 2.4× 331 2.7× 79 0.7× 16 1.0k
Xujuan Yang United States 14 517 1.9× 495 2.0× 513 3.0× 187 1.5× 119 1.1× 15 1.2k
Baoyue Ding China 18 203 0.8× 258 1.0× 372 2.2× 44 0.4× 59 0.6× 50 860

Countries citing papers authored by Ruby Gupta

Since Specialization
Citations

This map shows the geographic impact of Ruby Gupta's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ruby Gupta with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ruby Gupta more than expected).

Fields of papers citing papers by Ruby Gupta

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ruby Gupta. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ruby Gupta. The network helps show where Ruby Gupta may publish in the future.

Co-authorship network of co-authors of Ruby Gupta

This figure shows the co-authorship network connecting the top 25 collaborators of Ruby Gupta. A scholar is included among the top collaborators of Ruby Gupta based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ruby Gupta. Ruby Gupta is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Joshi, Arti, et al.. (2023). A polyoxomolybdate-based hybrid nano capsule as an antineoplastic agent. Nanoscale Advances. 5(22). 6045–6052. 2 indexed citations
3.
Kumar, Naveen, et al.. (2023). Evaluation of rice genotypes against rice leaf folder, Cnaphalocrosis medinelis Guenee in Koshi region of Bihar. Annals of Plant Protection Sciences. 31(2). 75–80. 1 indexed citations
4.
Goel, Manish Kumar, Zakir Husain, Ruby Gupta, et al.. (2022). Green synthesis of biocompatible superparamagnetic iron oxide-gold composite nanoparticles for magnetic resonance imaging, hyperthermia and photothermal therapeutic applications. Materials Chemistry and Physics. 293. 126859–126859. 36 indexed citations
6.
Gupta, Ruby, et al.. (2022). Tailoring nanoparticles design for enhanced heating efficiency and improved magneto-chemo therapy for glioblastoma. Biomaterials Advances. 139. 213021–213021. 12 indexed citations
7.
Gupta, Ruby & Deepika Sharma. (2021). Therapeutic response differences between 2D and 3D tumor models of magnetic hyperthermia. Nanoscale Advances. 3(13). 3663–3680. 21 indexed citations
8.
Gupta, Ruby & Deepika Sharma. (2021). (Carboxymethyl-stevioside)-coated magnetic dots for enhanced magnetic hyperthermia and improved glioblastoma treatment. Colloids and Surfaces B Biointerfaces. 205. 111870–111870. 21 indexed citations
9.
Gupta, Ruby, Ruchi Tomar, Suvankar Chakraverty, & Deepika Sharma. (2021). Effect of manganese doping on the hyperthermic profile of ferrite nanoparticles using response surface methodology. RSC Advances. 11(28). 16942–16954. 15 indexed citations
10.
Gupta, Ruby & Deepika Sharma. (2020). Manganese-Doped Magnetic Nanoclusters for Hyperthermia and Photothermal Glioblastoma Therapy. ACS Applied Nano Materials. 3(2). 2026–2037. 60 indexed citations
11.
Joshi, Arti, Ruby Gupta, Kalpesh Vaghasiya, et al.. (2020). In Vitro Anti-tumoral and Anti-bacterial Activity of an Octamolybdate Cluster-Based Hybrid Solid Incorporated with a Copper Picolinate Complex. ACS Applied Bio Materials. 3(7). 4025–4035. 13 indexed citations
12.
Joshi, Arti, Ruby Gupta, Deepika Sharma, & Monika Singh. (2020). A Mo(vi) based coordination polymer as an antiproliferative agent against cancer cells. Dalton Transactions. 50(4). 1253–1260. 6 indexed citations
13.
Joshi, Arti, Ruby Gupta, Bharti Singh, Deepika Sharma, & Monika Singh. (2020). Effective inhibitory activity against MCF-7, A549 and HepG2 cancer cells by a phosphomolybdate based hybrid solid. Dalton Transactions. 49(21). 7069–7077. 19 indexed citations
14.
Gupta, Ruby & Deepika Sharma. (2019). Evolution of Magnetic Hyperthermia for Glioblastoma Multiforme Therapy. ACS Chemical Neuroscience. 10(3). 1157–1172. 76 indexed citations
15.
Gupta, Ruby, et al.. (2018). The impact of microsatellite stability status in colorectal cancer. Current Problems in Cancer. 42(6). 548–559. 78 indexed citations
16.
Gupta, Ruby, et al.. (2014). PHYTOCHEMICAL SCREENING AND ANTIMICROBIAL ASSAY OF VARIOUS SEEDS EXTRACT OF CUCURBITACEAE FAMILY. 24 indexed citations
17.
Gupta, Ruby, et al.. (2010). Potentiative activity of Cucurbita maxima seed extract with Beta vulgaris & Smilax regelii root extract to reduce extra fats from the body.. International Journal of Pharmaceutical Sciences and Research. 1(2). 56–62. 3 indexed citations
18.
Gupta, Sanjiv, et al.. (1998). Breast Metastasis of Cervical Carcinoma Diagnosed by Fine Needle Aspiration Cytology. Acta Cytologica. 42(4). 959–962. 16 indexed citations
19.
Srivastava, Vaibhav, et al.. (1995). Variability in total bitters in Tinospora cordifolia (willd.) miers populations. Indian Journal of Plant Genetic Resources. 8(1). 49–56. 1 indexed citations
20.
Gupta, Ruby, et al.. (1975). Rules for Germination Test of Tree Seeds for Certification. Indian Forester. 101(6). 320–327. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026